Ikarian Capital, LLC 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Ikarian Capital, LLC disclosed 127 US equity positions worth $699.0m in its Q1 2026 13F filing. The largest position was 430 at 11.0% of the reported book, followed by KOD and ALMS.
What did Ikarian Capital, LLC own in Q1 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | 430 TERNS PHARMACEUTICALS INC | 11.0% | $76.8m | 1,456,378 | – | ||
| 2 | KOD KODIAK SCIENCES INC | Healthcare | 6.9% | $48.3m | 1,265,795 | – | |
| 3 | ALMS ALUMIS INC | Healthcare | 3.8% | $26.7m | 1,213,548 | – | |
| 4 | PCVX VAXCYTE INC | Healthcare | 3.6% | $24.9m | 428,682 | – | |
| 5 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 3.3% | $23.1m | 71,581 | – | |
| 6 | HROW HARROW INC | 2.7% | $19.1m | 543,047 | – | ||
| 7 | RLMD RELMADA THERAPEUTICS INC | Healthcare | 2.7% | $18.7m | 2,688,359 | – | |
| 8 | CYTK CYTOKINETICS INC | Healthcare | 2.7% | $18.7m | 283,572 | – | |
| 9 | TENX TENAX THERAPEUTICS INC | 2.3% | $16.3m | 1,017,600 | – | ||
| 10 | CAPR CAPRICOR THERAPEUTICS INC | Healthcare | 2.3% | $16.1m | 528,015 | – | |
| 11 | RVMD REVOLUTION MEDICINES INC | Healthcare | 2.3% | $15.9m | 163,142 | – | |
| 12 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 2.1% | $14.6m | 461,247 | – | |
| 13 | PHVS PHARVARIS N V | Healthcare | 2.0% | $13.8m | 486,856 | – | |
| 14 | CNTB CONNECT BIOPHARMA HLDGS LTD | 1.9% | $13.1m | 5,388,486 | – | ||
| 15 | DRUG BRIGHT MINDS BIOSCIENCES INC | Healthcare | 1.7% | $12.2m | 166,647 | – | |
| 16 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 1.7% | $11.9m | 160,120 | – | |
| 17 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 1.7% | $11.9m | 242,021 | – | |
| 18 | ANRO ALTO NEUROSCIENCE INC | Healthcare | 1.7% | $11.6m | 515,000 | – | |
| 19 | SLNOEUR SOLENO THERAPEUTICS INC | 1.6% | $11.5m | 344,123 | – | ||
| 20 | MAZE MAZE THERAPEUTICS INC | Healthcare | 1.6% | $11.3m | 378,999 | – | |
| 21 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 1.6% | $11.3m | 147,085 | – | |
| 22 | CTNM CONTINEUM THERAPEUTICS INC | 1.5% | $10.6m | 807,874 | – | ||
| 23 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 1.4% | $10.1m | 482,571 | – | |
| 24 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 1.4% | $9.5m | 127,038 | – | |
| 25 | OLMA OLEMA PHARMACEUTICALS INC | Healthcare | 1.3% | $8.9m | 598,281 | – | |
| 26 | EPRX EUPRAXIA PHARMACEUTICALS INC | 1.3% | $8.8m | 1,214,741 | – | ||
| 27 | DMRA DAMORA THERAPEUTICS INC | Healthcare | 1.2% | $8.7m | 335,710 | – | |
| 28 | PVLA PALVELLA THERAPEUTICS INC NE | Healthcare | 1.2% | $8.1m | 64,626 | – | |
| 29 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 1.2% | $8.0m | 1,049,161 | – | |
| 30 | VERA VERA THERAPEUTICS INC | Healthcare | 1.2% | $8.0m | 200,000 | – | |
| 31 | SPRB SPRUCE BIOSCIENCES INC | 1.1% | $7.9m | 121,356 | – | ||
| 32 | IVA INVENTIVA SA | 1.1% | $7.8m | 1,429,101 | – | ||
| 33 | JBIO JADE BIOSCIENCES INC | Healthcare | 1.0% | $7.2m | 512,349 | – | |
| 34 | OCGN OCUGEN INC | Healthcare | 1.0% | $7.2m | 3,962,972 | – | |
| 35 | ZURA ZURA BIO LTD | Healthcare | 1.0% | $7.1m | 1,193,492 | – | |
| 36 | OVID OVID THERAPEUTICS INC | Healthcare | 0.9% | $6.4m | 2,894,704 | – | |
| 37 | ABVX ABIVAX SA | Healthcare | 0.9% | $6.2m | 57,635 | – | |
| 38 | LLY ELI LILLY & CO | Healthcare | 0.9% | $6.0m | 6,547 | – | |
| 39 | ALPHA COGNITION INC | 0.8% | $5.8m | 1,056,259 | – | ||
| 40 | PELTHOS THERAPEUTICS INC | 0.8% | $5.4m | 256,598 | – | ||
| 41 | SRZN SURROZEN INC | 0.7% | $5.0m | 173,107 | – | ||
| 42 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 0.7% | $4.9m | 157,537 | – | |
| 43 | ALEC ALECTOR INC | Healthcare | 0.6% | $4.5m | 2,082,606 | – | |
| 44 | LEGN LEGEND BIOTECH CORP | Healthcare | 0.6% | $4.1m | 226,888 | – | |
| 45 | KPTI KARYOPHARM THERAPEUTICS INC | 0.6% | $4.1m | 733,435 | – | ||
| 46 | LPCN LIPOCINE INC NEW | 0.6% | $4.1m | 508,556 | – | ||
| 47 | DCTH DELCATH SYS INC | 0.6% | $4.0m | 431,251 | – | ||
| 48 | ARVN ARVINAS INC | Healthcare | 0.5% | $3.8m | 358,257 | – | |
| 49 | CMPS COMPASS PATHWAYS PLC | Healthcare | 0.5% | $3.7m | 675,000 | – | |
| 50 | CRDL CARDIOL THERAPEUTICS INC | 0.5% | $3.7m | 2,725,000 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.